display:none
Skip to main content

Celebrating five years of impact at DiMe: Thank you for your contributions

Work with DiMe on an upcoming project

This course is newly updated with evidence, research, and case studies from 2023!

Online Course

Fast Track to Digital Clinical Trials for Pharma – Plus

A digital strategy can no longer lie within a siloed digital or innovation team. It’s critical to integrate digital across the enterprise maintain a competitive edge

Did you know?

As of April 2023, 104 unique sponsor organizations have leveraged digital endpoints in clinical studies?

Digital Medicine Academy course logo--an image of a laptop with a motorboard surrounded by the course name "Fast Track to Digital Clinical Trials For Pharma"

Course Overview

This course features the most robust evidence, best practices, and guiding principles. Content is based on DiMe-generated research and other high-quality sources such as relevant regulatory guidance. Learn about the latest and greatest in digital medicine from the very best — poising your organization and your teams for professional and business success.

Course Features

Each course contains:

  • Interactive content presented in multiple formats for self-directed learning
  • Video snippets from key opinion leaders who are subject matter experts relevant topics
  • Knowledge checks via interactive activities
  • Additional resources such as use cases, tools, and/or a curated digest of relevant peer-reviewed publications

Accessible to learners who are hard of hearing and/or visually impaired

Single sign-in options with Office 365, LinkedIn, and/or Google

Ready to get started?

More Courses Coming Soon

The Digital Medicine Academy is committed to offering valuable lessons in pace with the evolving digital healthcare field. Check back for new course offerings.

DiMe in the News

Recent articles discussing the current landscape in digital medicine

Join our next project

Help streamline the path to regulatory and commercial success to optimize health outcomes for the greatest number of patients

Join the Integrated Evidence Plans project

Join us
Not today